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INTRODUCTION
Nemaline Rod Disease, otherwise known as Nemaline
Myopathy (NM) is a congenital myopathy characterized
by hypotonia, muscle weakness and often skeletal
deformities with the presence of  nemaline rods in the
muscle biopsy1-3. Facial and respiratory muscles can
be involved in NM and several patients with the
condition have been known to experience respiratory
failure2-4. Cardiac involvement, particularly dilated
cardiomyopathy, may occur 3,4 and cardiac and
respiratory involvement have been documented as
indices of worse prognosis1,2.
Myasthenia Gravis (MG) is a group of autoimmune
neuromuscular diseases characterized by abnormal
neurotransmission at the motor endplate resulting from
destruction of acetylcholine receptors by anti
acetylcholine receptor antibodies3,4. It is characterized
by varying degree of muscle weakness, most patients
(85%) presenting with ocular symptoms ranging from
ptosis, diplopia or blurred vision while others could
present with leg, arm, face, neck and trunk weakness,
bulbar symptoms and generalized fatigue 4.
Autoimmune MG in children is most commonly
divided into neonatal transient and juvenile types, onset
of which is usually after 10 years of age4. Without
treatment, MG can become progressive and life
threatening, especially when the bulbar and respiratory
muscles are affected1, 2. The heart is not involved in
myasthenia gravis and electrocardiographic findings
remain normal while roentgenogram of  the chest often
reveals an enlarged thymus1. Most patients usually
respond well to anticholinesterases with or without a
variety of immunosuppressive medications2.
We present the case of  an 11 year old Nigerian girl
with suspected nemaline rod disease.
CASE REPORT
AAM was an eleven year old female adolescent who
was referred from a tertiary paediatric centre to the
Paediatric Neurology Clinic, University College
Hospital, Ibadan on account of drooping of the
eyelids of 2 years duration, easy fatigability and
breathlessness of 6 months duration and 1 week history
of swollen feet.
She was apparently well until 2 years prior to
presentation when she developed drooping of both
eyelids which usually worsened as the day progressed.
There was associated limbs weakness, difficulty with
swallowing of solid diet and occasionally of liquids
with concormitant reduced calorie intake and weight
loss over about 18 months. She was initially
commenced on oral Pyridostigmine and Prednisolone
without any significant improvement and later tried
on oral Neostigmine which improved ocular
symptoms but was later discontinued when patient
developed severe diarrhoea. She was admitted twice
in the 4 months preceding her presentation at our
facility on account of severe respiratory distress, during
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one of which she was placed on mechanical ventilation.
A week prior to presentation, her condition
deteriorated with severe effort intolerance, difficulty
with breathing, orthopnoea, Paroxysmal Nocturnal
Dyspnoea (PND) and swelling of both feet all of
which were not associated with cough or change in
urinary output and frequency. There was no history
of  bluish discoloration of  the lips or extremities.
Pregnancy, delivery and neonatal periods were
uneventful and developmental milestones were within
normal limits. She was born into a monogamous
family setting and there was no similar history in any
other member of  the family.
Findings on examination revealed a chronically ill girl,
mildly pale with bilateral periorbital and peripheral
oedema up to the mid-thigh, anicteric, not cyanosed
and without significant peripheral lymphadenopathy.
She was dyspnoeic with flaring of the alae nasi and
shallow respiratory excursions. Respiratory rate was
36 cycles per minute with fine crepitations at the right
lung base. Pulses were small volume and regular with
a rate of 124 beats per minute. Blood pressure was
100/60mmHg, Jugular venous pressure was raised.
The apex beat was displaced to the fifth left intercostal
space lateral to the mid-clavicullar line. Auscultation
revealed a gallop rhythm with a loud pulmonic
component of  the second heart sounds. The abdomen
was distended with ascites demonstrable by shifting
dullness and a non-tender hepatomegaly measuring
2cm below the right costal margin. She was conscious,
alert and well-oriented with intelligent conversation.
There was no ptosis or opthalmoplegia on arrival.
Cranial nerves were intact with normal muscle tone
and grade 5 muscle power in all limbs. Gait was normal.
An assessment of background Myasthenia Gravis in
remission with Cor Pulmonale to rule out
Cardiomyopathy and Chronic renal failure was made.
She was commenced on intravenous frusemide 40mg
(1mg/kg/dose) 8 hourly for 24 hours and oral
spironolactone, hydrochlorothiazide and lisinopril.
Electrolyte, Urea and Creatinine were within normal
limits. Chest x-ray showed cardiomegaly
(Cardiothoracic ratio = 66%) and fluffy cotton wool
opacities in both middle and lower lung zones. No
enlargement of thymic shadow was noticed.
Electrocardiographic features were in keeping with
right ventricular hypertrophy while Echocardiography
by the paediatric cardiologist showed biventricular
dysfunction worse on the right, all in keeping with
cardiomyopathy. Patient was reported to be
seronegative for acetycholine receptor antibody at the
referral centre.
She was recommenced on low dose pyridostigmine
(30mg qds) on the second day of admission, having
been off the medication and oral prednisolone for
about 3 weeks prior to presentation. This was however
discontinued on the third day when she developed
tremors and muscle fasiculations after about 24 hours
of commencement. About 42 hours into admission,
she developed worsening respiratory distress
necessitating Intensive Care Unit admission with
mechanical ventilation. She was subsequently reviewed
after which MG was then considered unlikely  on the
basis of (1) Lack of  response to anticholinergic agents;
(2) repeated episodes of cholinergic crisis even with
low dose anticholinesterase; (3) lack of response to
corticosteroids; (4)features of congestive cardiac failure
with acute pulmonary oedema and (5) recurrent
episodes of severe respiratory distress requiring
mechanical ventilation. A possibility of Congenital
myopathy ? type to keep in view Nemaline Rod Disease
with respiratory muscle weakness was subsequently
entertained.
She was weaned off anticholinesterase and
Electromyography, Muscle biopsy and serum
creatinine kinase were requested but could not all be
done before demise. Clinical conditions remain
turbulent until she succumbed to the illness on the fifth
day of admission.
DISCUSSION
It is well documented in the literature that ocular
symptoms (ptosis, diplopia or blurred vision) are the
earliest, commonest and the most constant signs in
patients with MG1,2. It is therefore not surprising that
MG was the foremost diagnosis considered in the
management of this patient. The presence of limb
weakness and associated difficulty in swallowing further
strengthened this consideration. Although MG could
sometimes present with respiratory difficulty especially
when not promptly diagnosed and treated, most of
the patients respond well to anticholinesterase and
immunosuppressive therapy1,2. The poor response of
this patient to anticholinesterase and immuno-
suppressive therapy with prednisolone, which is
considered by many as the most effective oral
immunosuppressive agent in MG 2, the presence of
recurrent respiratory difficulty requiring mechanical
ventilation and cardiac involvement in this patient add
weight to the possibility of NM, a condition which
has been reported to be associated with facial and limb
weaknesses, cardiac involvement and respiratory
failure3-5 all of which were present in this patient.
Our inability to obtain muscle biopsy for definitive
diagnosis in this patient before her demise makes
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diagnostic challenges in a developing economy like ours
very obvious. Six different forms of  NM have been
described with variable prognoses6 while several
authors have reported variable clinical manifestations
of the conditions from infants with the infantile type
through adolescent to the adults forms3,7, 8 but sufficient
data depicting the condition in Nigerian and African
children are lacking. However, the onset of  symptoms
in this patient in late childhood suggest she had the
juvenile variant of NM. In addition, the fact that patient
was a female with symptoms beginning with drooping
of the eyelids before involvement of other muscle
groups make the diagnosis of muscular dystrophy
unlikely.
Tensilon test could not be done in this patient because
of  its inavailability. Although neostigmine was available
and could have been utilized as an alternative, patient
had earlier showed adverse effect when she was tried
on neostigmine in the past ( She had profuse diarrhoea
when she was tried on neostigmine as earlier stated).
Hence, attempting neostigmine test in the setting of
such adverse reaction could have been fatal and might
have accelerated patient’s demise.  Even when low dose
pyridostigmine was commenced as an alternative,
patient still manifested adverse effect on the second
day which eventually led to the withdrawal of
anticholinesterase from her therapy. We acknowledge
that ice pack test should have been performed in this
patient since it is very cheap and reports has shown
that cold improves neuromuscular transmission9. This
could have further assisted in clarifying the diagnosis.
However, situations in which ice pack test was positive
in patients with ptosis and underlying diagnosis still
remain unclear have been reported, thus leading to a
cautionary note on relying on it solely for diagnosis of
myasthenia gravis9. Plasmapheresis and intravenous
immunoglobulin were not readily available for
utilization during the course of management.
Although evidences abound that NM is a genetic disease
commonly involving the mutation of the nebulin gene10,
there have been documented reports of its
demonstration in Human Immunodeficiency Virus
(HIV) myopathies4,11, thus suggesting a possible
autoimmune component in its aetiopathogenesis.
There is no cure for NM as at present12. Some patients
with the disorder are able to lead an active life,
especially when there is no cardiac and respiratory
involvement3.
Patients with cardiac involvement have been reported
to benefit from Angiotensin Converting Enzyme
inhibitors, â blockers or angiotensin receptor blocker4
while some authors have  documented the beneficial
effects of L-tyrosine, a non-essential amino acid which
is a precursor or catecholamines which possibly explain
its beneficial effects6. Ivabradine, a cardiotonic agent,
has been used in some patients with NM who
developed heart failure unresponsive to â blockers11.
CONCLUSION
Although this report is limited by lack of definitive
diagnosis with muscle biopsy, the diagnostic puzzle
between MG and NM at the presentation of this
patient is very obvious and the eventual consideration
of NM during a later review in the course of
management on the ground of previous history of
facial weakness, dysphagia, respiratory and cardiac
involvement and poor response to anticholinesterase
and immunosuppressive therapy with oral
prednisolone agrees with documented clinical course
of NM3-5, while the presence of respiratory failure
and cardiovascular compilations likely worsened the
prognosis in this patient. We wish to therefore sensitize
clinicians in resource poor setting and developing
economies to these rare conditions which could
sometimes present as diagnostic and management
challenges.
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